PRESS AREA

This section is dedicated to the media, and it collects press releases on Gianni Bonadonna Foundation’s activities.

Press Release, September 6th 2023
Identifying tumour characteristics as predictors of immunotherapy response in aggressive breast cancers. Published the results of an new research from the Cancer Research UK Cambridge Institute and Fondazione Michelangelo in Nature.
Download

Press Release, February 10th 2023
Announced on the International Day of Women in Science, the winning project of the second edition of the first edition of the Call for proposals “Gianni Bonadonna” Fellowships, funded by Fondazione Gianni Bonadonna, with Prada Group as supporting partner, and Fondazione AIRC
Download

Press Release, September 14th 2022
Phost’In Therapeutics in collaboration with Fondazione Gianni Bonadonna, announces the dosing of the first three patients in the Dose Escalation phase of the PhAST trial, a Phase I study in patients with advanced solid tumors
Download

Press Release, June 7th 2022
Phost’In Therapeutics announces approval of French and Italian Health Agencies for a first European clinical trial application in patients with advanced solid tumors, in collaboration with Fondazione Gianni Bonadonna: PhAST Trial
Download

Press Release, February 11th 2022
To mark the International Day of Women in Science, Fondazione Gianni Bonadonna, with Prada Group as supporting partner, and Fondazione AIRC are happy to announce the winners of the first edition of the Call for proposals “Gianni Bonadonna” Fellowships
Download

Press Release, April 21th 2021
“Gianni Bonadonna Foundation – with Prada Group as supporting partner – and Fondazione AIRC announce the call for applications for the international fellowships in honor of Gianni Bonadonna”
Download

Press Release, October 11th 2018
“Prada Group and Gianni Bonadonna Foundation working together on an innovative cancer treatment and research project”
Download